125 related articles for article (PubMed ID: 9023669)
1. Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated urinary bladder.
Giuliani S; Patacchini R; Lazzeri M; Benaim G; Turini D; Quartara L; Maggi CA
J Auton Pharmacol; 1996 Oct; 16(5):251-9. PubMed ID: 9023669
[TBL] [Abstract][Full Text] [Related]
2. Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated ileum and colon.
Patacchini R; Giuliani S; Lazzeri M; Turini A; Quartara L; Maggi CA
Neuropeptides; 1997 Feb; 31(1):71-7. PubMed ID: 9574841
[TBL] [Abstract][Full Text] [Related]
3. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
4. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
5. Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
Tramontana M; Patacchini R; Lecci A; Giuliani S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):293-300. PubMed ID: 9774215
[TBL] [Abstract][Full Text] [Related]
6. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
Giuliani S; Patacchini R; Barbanti G; Turini D; Rovero P; Quartara L; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):590-5. PubMed ID: 8246132
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the existence of NK2 tachykinin receptor subtypes.
Patacchini R; Astolfi M; Quartara L; Rovero P; Giachetti A; Maggi CA
Br J Pharmacol; 1991 Sep; 104(1):91-6. PubMed ID: 1664768
[TBL] [Abstract][Full Text] [Related]
9. Activity of SR 142801 at peripheral tachykinin receptors.
Patacchini R; Barthò L; Holzer P; Maggi CA
Eur J Pharmacol; 1995 May; 278(1):17-25. PubMed ID: 7545122
[TBL] [Abstract][Full Text] [Related]
10. Amastatin interferes with the antagonist properties of MEN 10,208 in the rabbit pulmonary artery but not in the hamster trachea.
Patacchini R; Maggi CA
Eur J Pharmacol; 1993 May; 236(1):31-7. PubMed ID: 8391454
[TBL] [Abstract][Full Text] [Related]
11. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
[TBL] [Abstract][Full Text] [Related]
12. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
[TBL] [Abstract][Full Text] [Related]
13. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
14. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
16. A review of the design, synthesis and biological activity of the bicyclic hexapeptide tachykinin NK2 antagonist MEN 10627.
Quartara L; Pavone V; Pedone C; Lombardi A; Renzetti AR; Maggi CA
Regul Pept; 1996 Aug; 65(1):55-9. PubMed ID: 8876036
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist.
Maggi CA; Patacchini R; Giuliani S; Giachetti A
Eur J Pharmacol; 1993 Mar; 234(1):83-90. PubMed ID: 8386095
[TBL] [Abstract][Full Text] [Related]
18. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
[TBL] [Abstract][Full Text] [Related]
20. MEN 10,573 and MEN 10,612, novel cyclic pseudopeptides which are potent tachykinin NK-2 receptor antagonists.
Maggi CA; Quartara L; Patacchini R; Giuliani S; Barbanti G; Turini D; Giachetti A
Regul Pept; 1993 Sep; 47(2):151-8. PubMed ID: 8234901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
